..............................

Home

About Us

Group Companies
Management
Products
Business Units
Exports
Financials
Shareholder's Info
Alliances
Kopran R&D
Kopran Lab.
Contact
Site Map

..............................

Disclaimer  

Active Pharmaceutical Ingredients
______________________________________________________________________

Kopran manufactures a range of APIs including Sterile Cephalosporins in its state of art facility at Mahad, Maharashtra.  Manufacturing of any Sterile API needs excellent facility and quality systems.  Kopran has always been a major player in the manufacturing of Sterile Cephalosporins.  Apart from Sterile API, we can provide a range of Speciality products which include Macrolides and Cardiovascular range among others.  For many of our APIs, we hold Certificate of Suitability.

European Directorate for Quality of Medicines (EDQM)
  Atenolol (COS)
  Cephalosporin (Non Sterile)
  Cephalosporin (Sterile) - under approval  

Manufacturing Facilities
The division has a well defined quality management system and Good Manufacturing
Practice (‘GMP’).

Leveraging on the in house expertise and in house research, this division
has concentrated on high value drugs which require technological expertise
.

Built in 1996, spread over 36,000 sq. mtrs. within Maharashtra Industrial 
Development Corporation (MIDC) Mahad, built as per FDA norms and complying 
with WHO norms, the plant is a versatile plant capable of manufacturing 
over 20 products.

The manufacturing facility is well supported by a state of the art contained Pilot plant
for the purpose of scaling up of the process.

The industrial effluent treatment plant has a installed capacity of treating 250 m3/day
with a total connected load of 150 H.P treating nearly 150 m3 of water daily.

A whole range of Pharmaceutical raw materials primarily high value in various
therapeutic groups :

  Anti-Infectives (both Sterile and Oral)
  Cardiology
  Gastroenterology
  Analgesics
  Anti-AIDS

Process Capabilities
Production of Chemical Intermediates and Active Pharmaceutical Ingredients by:

1. Acrylation 12. High Pressure Hydrogenation
2. Alkylation 13. Haloganation
3. Amination 14. Mannich Base Reaction
4. Cyclisation 15. Nitration 
5. Condensation 16. Oxidation
6. Chlorosulphonation 17. Oximation
7. Epoxidation 18. Protection and Deprotection
8. Enzymatic Hydrolysis 19. Pressure reaction
9. Esterification 20. Reduction
10. Friedal Craft Reaction 21. Silylation
11. Grignard Reaction . .


Manufacturing Capabilities
Our production plant contains-
  Reaction vessels with volumes from 50 ltrs. to 9000 ltrs. working under vacuum and 
   pressure upto 30 kgs. Total working capacity of all the vessels together is 127000 ltrs.
  Facility to go upto the temp. 150oC and as low as (-)95oC.
  Reaction vessels of various material of construction viz. stainless steel, carbon steel, 
   glass lined, tiled lined, carbon lined etc. 
  Pelletisation machines.
  Rectification and distillation columns.
  Centrifuges.
  Vacuum and pressure filters.
  Various types of dryers.
  Various types of micronisers.
  Dedicated facility for Sterile product manufacturing.
  Processing plant for water, waste and waste air.

These plants facilitate the production of various organic intermediates and bulk pharmaceutical chemicals (APIs). The high quality standard of our products is guaranteed by production according to the cGMP regulation. Facilities meet current requirement of various regulatory authorities with several active Drug Master Files.

The extensive experience in Organic Chemistry coupled with GMP capabilities allows Kopran 
to provide its customers with a wide range of services in Organic Synthesis for custom manufacturing and the production of active pharmaceutical ingredients.

The team of dedicated Scientists with a state of the art Research Centre supported by pilot plant can meet the challenges of increasing customer demands as well as responding to our responsibilities for the environment.

The independence of the Research team means that customers are assured that Contract Research is carried out confidentially and exclusively.

______________________________________________________________________

For more detail information, Contact us.


Up

 

                                  Home | About Us | Group Companies | Management | Products | Business Units | Exports | Financials   
                                   Shareholder's Info | Alliances | Kopran Research Lab. | Kopran Laboratories Ltd.
                      Contact | Site Map

                                                                                                                   Copyright 2000 KOPRAN LTD.
                                                                        
(This site is best viewed with Internet Explorer 5.0 or higher version at 1024x768 screen resolution)